Podcasts

Episode 47 | Introducing Conversations in Lung Cancer Research

In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to ‘Conversations in Lung Cancer Research.’

Episode Summary

In this introductory episode, A/Prof Mel Moore, medical oncologist and education chair at TOGA, announces the evolution of TOGA podcasts to ‘Conversations in Lung Cancer Research.’ The podcast will continue to deliver the latest breakthroughs in lung cancer research while expanding to include deeper dives and engaging discussions with experts in thoracic oncology. Listeners can look forward to unique insights from researchers, clinicians, and key thought leaders shaping the future of lung cancer care.

 

 Show Hosts

  • A/Prof Melissa Moore, Medical Oncologist at St Vincents Hospital and TOGA Education Chair.
Text Conversations in Lung Cancer on Blue background and TOGA logo

Play Episode 47 | Introducing Conversations in Lung Cancer Research

More Podcasts

Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.
Host A/Prof Rachel Roberts-Thomson leads a panel discussion focusing on the landscape of BRAF-mutated non-small cell lung cancer.
In this episode of TOGA's Conversations in Lung Cancer Research, host A/Prof Malinda Itchins, a medical oncologist and clinician researcher at Royal North Shore Hospital
In this episode, we welcome A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health.